22nd Century Group, Inc. Files 2019 Annual Report

WILLIAMSVILLE, N.Y.–(BUSINESS WIRE)–22nd Century Group, Inc. (NYSE American: XXII), a leading plant biotechnology company in reduced nicotine tobacco and hemp/cannabis plant genetics research and development, yesterday filed its Annual Report on Form 10-K f…
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *